Today: 25 April 2026

CLSD Stock Crashes Over 60% Today as Clearside Biomedical Files for Chapter 11 Bankruptcy

CLSD Stock Crashes Over 60% Today as Clearside Biomedical Files for Chapter 11 Bankruptcy

Clearside Biomedical filed for Chapter 11 bankruptcy Monday and will seek a court-supervised sale of its assets. CLSD stock plunged nearly 68% to around $0.88 by late afternoon, hitting a new 52-week low after closing at $2.69 Friday. Trading volume spiked to roughly 12 times normal levels. The company cited “substantial doubt” about its ability to continue as a going concern in its latest quarterly filing.
24 November 2025
ASX Today: 10 Things to Know Before the Australian Stock Market Opens on 25 November 2025

ASX Today: 10 Things to Know Before the Australian Stock Market Opens on 25 November 2025

The ASX 200 surged 1.3% to 8,525.10 on Monday, its strongest session since July, with futures up 0.45% ahead of Tuesday’s open. Wall Street rallied overnight, led by tech stocks, after dovish signals from US Federal Reserve officials boosted hopes for a December rate cut. Iron ore prices held above US$104 per tonne. Traders await key Australian inflation data due Tuesday.
24 November 2025
Japan Stock Market Opening Preview for Nov. 25, 2025: Nikkei Futures, BOJ Rate Hike Bets, Rapidus Funding and China Travel Boycott in Focus

Japan Stock Market Opening Preview for Nov. 25, 2025: Nikkei Futures, BOJ Rate Hike Bets, Rapidus Funding and China Travel Boycott in Focus

Japan’s cash equity market reopens Tuesday after a holiday, with Nikkei 225 futures pointing to a firmer start following a sharp Wall Street rally. The yen trades near 10-month lows at ¥156–157 per dollar, raising FX intervention risk. The Nikkei last closed at 48,625.88, down 2.4%, about 5% below its October record. Investors face fresh GDP concerns, government debt worries, and signs of strong wage hikes ahead of the next BOJ meeting.
24 November 2025
Singapore Stocks Outlook: 10 Things to Know Before the SGX Opens on 25 November 2025

Singapore Stocks Outlook: 10 Things to Know Before the SGX Opens on 25 November 2025

Singapore’s Straits Times Index rose 0.6% to 4,496.63 on Monday, staying close to its all-time high after the government nearly doubled its 2025 GDP growth forecast to around 4%. Jardine Matheson jumped 8.7%, while Singapore Exchange fell 1.1%. Turnover reached S$3.2 billion. Investors are watching for follow-through as global markets rebound on hopes of a US Fed rate cut.
Bloom Energy (BE) Stock Today: AI Power Darling Rebounds as New Institutional Money Arrives — November 24, 2025

Bloom Energy (BE) Stock Today: AI Power Darling Rebounds as New Institutional Money Arrives — November 24, 2025

Bloom Energy shares rose 5.2% to $94.69 in late trading November 24, rebounding after last week’s 40% plunge. Covalis Gibraltar Ltd disclosed a new 55,031-share stake worth $1.3 million, making Bloom its second-largest holding. Volume topped 12.7 million shares. The stock remains up over 400% for 2025 despite recent volatility.
JPMorgan Chase & Co. (JPM) Stock Today – Crypto Boycott Backlash, Data‑Breach Fallout and Dividend Strength on November 24, 2025

JPMorgan Chase & Co. (JPM) Stock Today – Crypto Boycott Backlash, Data‑Breach Fallout and Dividend Strength on November 24, 2025

JPMorgan Chase shares closed Monday at $299, just below record highs, with trading volume under 4.2 million shares. The bank faced backlash after closing Strike CEO Jack Mallers’ accounts and issuing a research note warning of potential $8.8 billion outflows from Bitcoin-linked firm Strategy. Calls to boycott JPMorgan trended in crypto circles.
GPUS Stock Today, November 24, 2025: Hyperscale Data Jumps After Joining Top 100 Bitcoin Treasuries – Price, News and Outlook

GPUS Stock Today, November 24, 2025: Hyperscale Data Jumps After Joining Top 100 Bitcoin Treasuries – Price, News and Outlook

Hyperscale Data Inc. (NYSE American: GPUS) shares rose about 12% to $0.28 Monday after the company announced it joined the global top 100 public Bitcoin treasury companies. Trading volume reached 30 million shares by mid-afternoon. GPUS stock remains down over 95% from its 52-week high near $10. The company now holds roughly 382 Bitcoin, up from 150 earlier this year.
CAVA Stock Today (Nov. 24, 2025): Price, Crash, and Outlook After the Q3 Earnings Shock

CAVA Stock Today (Nov. 24, 2025): Price, Crash, and Outlook After the Q3 Earnings Shock

Cava Group shares traded near $46.80 Monday afternoon, down about 4% and nearly 70% below last year’s high of $153.34. The stock has swung sharply this month, surging 12% on Nov. 21 before retreating. Third-quarter revenue rose 20% to $290 million, but Cava missed EPS estimates and cut its 2025 same-restaurant sales outlook. Market cap stands near $5.5 billion.
Nebius Group N.V. (NBIS) Stock Today, November 24, 2025: Soars Nearly 10% on Meta Deal Hype, Finland Campus Outlook and UBS Conference News

Nebius Group N.V. (NBIS) Stock Today, November 24, 2025: Soars Nearly 10% on Meta Deal Hype, Finland Campus Outlook and UBS Conference News

Nebius Group (NASDAQ: NBIS) surged nearly 10% to about $91 in late U.S. trading Monday, with volume topping 14 million shares. The rally follows new commentary on its Finland data-center campus, analyst upgrades, and an investor-relations event at the UBS Global Technology and AI Conference. The stock is rebounding from a 40% drop since October’s record high. Market cap stands just above $20 billion.
24 November 2025
BitMine Immersion (BMNR) Stock Today, November 24, 2025: Ethereum Hoard, Dividend and 16% Rally Explained

BitMine Immersion (BMNR) Stock Today, November 24, 2025: Ethereum Hoard, Dividend and 16% Rally Explained

BMNR shares surged 16% to $30 Monday after BitMine Immersion Technologies disclosed holding 3.63 million ETH, 192 Bitcoin, and $800 million in cash, totaling $11.2 billion in crypto and cash assets. More than 42 million shares traded, nearly double average volume. The company now holds about 3% of Ethereum’s circulating supply. BMNR remains over 80% below its 12-month high.
MRK Stock Today: Merck Jumps on Wells Fargo Upgrade and Keytruda Momentum (November 24, 2025)

MRK Stock Today: Merck Jumps on Wells Fargo Upgrade and Keytruda Momentum (November 24, 2025)

Merck shares climbed nearly 4% to around $101.40 by early afternoon Monday, nearing 2025 highs after Wells Fargo upgraded the stock to “Overweight” and raised its price target to $125. The move followed new FDA approvals and pipeline updates. Options activity surged, with call volume outpacing puts more than 3:1. Merck’s market cap stood at about $252 billion.
Dow Jones Today: Dow 30 Climbs About 300 Points on Fed Rate‑Cut Hopes and AI Stock Surge (November 24, 2025)

Dow Jones Today: Dow 30 Climbs About 300 Points on Fed Rate‑Cut Hopes and AI Stock Surge (November 24, 2025)

U.S. stocks surged Monday, with the Dow Jones closing up nearly 300 points at 46,545 and the Nasdaq jumping 2.7% to 22,874.95. Investors bet on a December Federal Reserve rate cut after dovish comments from Fed officials, driving one of the strongest two-day rallies for tech and AI shares this month. S&P 500 rose 1.65% to 6,711.80. Fed funds futures now show about 80% odds of a December cut.
S&P 500 Today: Around 1.5% Rally as Alphabet Leads Tech Comeback and Fed Cut Bets Jump (Nov. 24, 2025)

S&P 500 Today: Around 1.5% Rally as Alphabet Leads Tech Comeback and Fed Cut Bets Jump (Nov. 24, 2025)

The S&P 500 jumped 1.45% to near 6,700 on Monday, led by gains in tech and AI stocks including Alphabet and Tesla. The Nasdaq climbed about 2.5%, while the Dow rose 0.5%. Treasury yields fell to around 4.03% as traders sharply increased bets on a December Fed rate cut. A call between President Trump and China’s Xi also eased market tensions.
US Stock Market Today: Tech-Led Rally Lifts S&P 500 and Nasdaq as Fed Rate-Cut Bets Rise (November 24, 2025)

US Stock Market Today: Tech-Led Rally Lifts S&P 500 and Nasdaq as Fed Rate-Cut Bets Rise (November 24, 2025)

U.S. stocks rallied Monday, with the Nasdaq jumping 1.73% and the S&P 500 up 0.97%, as investors bet on a December Fed rate cut and responded to a thaw in U.S.–China relations. Mega-cap tech stocks led gains: Alphabet rose 6% after unveiling its Gemini 3 AI model, Tesla surged 7%, and chipmakers Broadcom and Micron climbed up to 10%. The Dow gained 0.32%.
BMY Stock Soars on Factor XIa Catalyst and Hematology Investor Event (Nov. 24, 2025)

BMY Stock Soars on Factor XIa Catalyst and Hematology Investor Event (Nov. 24, 2025)

Bristol Myers Squibb shares rose 4.3% to $48.24 Monday after renewed investor interest in Factor XIa blood-thinner drugs and its candidate milvexian. The company announced a hematology-focused virtual investor event for December 11. Despite the gain, BMY remains down about 14% for the year, trailing the S&P 500’s 13.6% rise. Q3 earnings beat expectations, with revenue up 3% to $12.2 billion.
24 November 2025

Stock Market Today

  • DLocal Lawsuit Dismissal Clears Legal Overhang, Shifts Focus to Valuation and Share Price Potential
    April 25, 2026, 12:25 PM EDT. New York's Appellate Division upheld dismissal of a securities class action lawsuit against DLocal (NasdaqGS:DLO), removing a significant legal overhang tied to its disclosures. The stock currently trades at $13.76, about 22% below the $17.75 analyst target, and 33.4% under estimated fair value according to Simply Wall St. The dismissal shifts investor attention back to business fundamentals, earnings quality, and cash flow generation. Despite the legal relief, broader regulatory, competitive, and execution risks remain. The stock has gained 55.3% over the past year and shows positive momentum with a 5.7% return over 30 days. Market watchers will likely focus on DLocal's future disclosure practices and strategic execution as they reassess its valuation and growth prospects.

Latest article

Intellia Therapeutics Stock Jumps After Hours Ahead of First Phase 3 In Vivo CRISPR Readout

Intellia Therapeutics Stock Jumps After Hours Ahead of First Phase 3 In Vivo CRISPR Readout

25 April 2026
CAMBRIDGE, Massachusetts, April 25, 2026, 12:07 (EDT) Intellia Therapeutics will report top-line data on Monday from HAELO, a late-stage trial of lonvoguran ziclumeran, its experimental one-time treatment for hereditary angioedema, setting up what the company calls the first Phase 3 readout for an in vivo CRISPR gene-editing candidate. In vivo means the gene edit is made inside the patient’s body, not in cells altered in a lab and returned by infusion. (Intellia Therapeutics) That makes the next update unusually important for Intellia and for the broader gene-editing field. A strong result could support a U.S. biologics license application, the filing
Rivian’s R2 Moment Is Here, and Traders Are Betting the Next Move Could Be Sharp

Rivian’s R2 Moment Is Here, and Traders Are Betting the Next Move Could Be Sharp

25 April 2026
Rivian has begun production of its R2 SUV at its Illinois plant, days before reporting first-quarter results on April 30. The new model targets a lower price point, with the base version set to launch around $45,000 in 2027. Options traders are bracing for a sharp move in the stock, which last traded near $16.50. A recent tornado damaged part of the factory roof, but Rivian said production plans remain unchanged.
eBay Inc. Stock Slides 5% as Depop Deal Faces UK Test Before Earnings

eBay Inc. Stock Slides 5% as Depop Deal Faces UK Test Before Earnings

25 April 2026
eBay shares fell 5.3% to $97.94 on Friday amid heightened regulatory scrutiny of its planned $1.2 billion Depop acquisition and ahead of its April 29 earnings call. Britain’s Competition and Markets Authority opened a merger file on April 23 but has not launched a formal investigation. Trading volume exceeded recent averages. Amazon shares rose 3.5% the same day.
Go toTop